KYNTRA BIO INC

KYNBNASDAQ

🏆 #3584 by market capEarnings Aug 13US Equity

$704.82▲ $6.77 (+0.96%)

Simulated price

1h—

24h▲ 1.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$29M

Small Cap

📈Revenue Growth (YoY)

-78.3%

Declining

📊Gross Margin

45.1%

Healthy

💵FCF Margin

-287.7%

Thin

⚖️P/S Ratio

3.8x

Fair

Otter Score

56

Weak

Earnings

Q1 · 2026Reported 2026-03-31

Earnings Per Share

Actual

-3.76

Expected

-3.42

miss

−9.90%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q1 2026

-3.76

miss

Q4 2025

-3.61

beat

Q3 2025

-3.25

beat

Q2 2025

-1.88

beat